| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Baxter International Inc (BAX) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. BAX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 465.7K | $8.12M | - | |
| CFO | 215.2K | $3.75M | - | |
| VP | 199.9K | $3.49M | - | |
| Pres | 128.2K | $2.24M | - | |
| VP | 106.3K | $1.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 | Chen Thomas F | Director | Sale+OE | 1,680 | $84.53 | $142,010.40 | -11.5% | -15.5% | -44.1% | |
| Feb 1, 2022 | Forsyth John D73 | Director | Sale+OE | 1,005 | $85.59 | $86,017.95 | -3.6% | -16.6% | -44.6% | |
| Nov 1, 2021 | Martin Sean | SVP And General Counsel | Sale+OE | 21,450 | $79.57 | $1,706,705.50 | -19.9% | +7.4% | -31.6% | |
| Aug 2, 2021 | Martin Sean | SVP And General Counsel | Sale+OE | 19,800 | $77.26 | $1,529,748.00 | -31.9% | +3.8% | -22.6% | |
| Apr 12, 2021 | Frye Andrew | SVP, President, Apac | Sell | 10,999 | $84.79 | $932,605.21 | -54.9% | -4.1% | -6.3% | |
| Apr 5, 2021 | Hellman Peter S | Director | Sale+OE | 4,990 | $84.56 | $421,954.40 | -16.4% | -4.6% | -9.0% | |
| Apr 5, 2021 | Stroucken Albert P L54 | Director | Sale+OE | 4,990 | $84.56 | $421,954.40 | -13.5% | -4.6% | -9.0% | |
| Nov 2, 2020 | Martin Sean | SVP And General Counsel | Sale+OE | 47,001 | $78.67 | $3,697,793.62 | -34.4% | - | - | |
| Sep 14, 2020 | Forsyth John D73 | Director | Sale+OE | 310 | $83.59 | $25,912.90 | -0.9% | - | - | |
| Aug 3, 2020 | Gavin James R III | Director | Sale+OE | 14,899 | $86.41 | $1,287,365.89 | -15.3% | - | - |